Diagnostic Medical Systems SA (ALDMS) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.001x

Based on the latest financial reports, Diagnostic Medical Systems SA (ALDMS) has a cash flow conversion efficiency ratio of -0.001x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-25.00K ≈ $-29.23K USD) by net assets (€20.66 Million ≈ $24.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ALDMS net asset quality score to measure how much of total assets are equity-financed.

Diagnostic Medical Systems SA - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Diagnostic Medical Systems SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Diagnostic Medical Systems SA earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Diagnostic Medical Systems SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Diagnostic Medical Systems SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Yellow Balloon Tour Co. Ltd KQ:104620	-0.292x
Itama Ranoraya JK:IRRA	-0.486x
Urbanfund Corp V:UFC	0.028x
HP Adhesives Limited NSE:HPAL	0.012x
Finetechnix. Co.Ltd KQ:106240	-0.063x
Unisync Corp TO:UNI	0.082x
Big 5 Sporting Goods Corporation NASDAQ:BGFV	-0.258x
Bayview Acquisition Corp Class A Ordinary Shares NASDAQ:BAYA	0.001x

Annual Cash Flow Conversion Efficiency for Diagnostic Medical Systems SA (2009–2025)

The table below shows the annual cash flow conversion efficiency of Diagnostic Medical Systems SA from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see Diagnostic Medical Systems SA market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€20.66 Million ≈ $24.16 Million	€-254.00K ≈ $-296.95K	-0.012x	-104.83%
2024-12-31	€14.16 Million ≈ $16.56 Million	€3.60 Million ≈ $4.21 Million	0.254x	+312.12%
2023-12-31	€13.72 Million ≈ $16.04 Million	€-1.65 Million ≈ $-1.92 Million	-0.120x	-326.87%
2022-12-31	€18.17 Million ≈ $21.24 Million	€960.00K ≈ $1.12 Million	0.053x	+199.71%
2021-12-31	€20.44 Million ≈ $23.89 Million	€-1.08 Million ≈ $-1.27 Million	-0.053x	+75.51%
2020-12-31	€17.05 Million ≈ $19.93 Million	€-3.69 Million ≈ $-4.31 Million	-0.216x	-982.13%
2019-12-31	€14.84 Million ≈ $17.35 Million	€364.00K ≈ $425.55K	0.025x	+160.07%
2018-12-31	€17.88 Million ≈ $20.90 Million	€-730.00K ≈ $-853.45K	-0.041x	+73.21%
2017-12-31	€23.35 Million ≈ $27.30 Million	€-3.56 Million ≈ $-4.16 Million	-0.152x	-437.35%
2016-12-31	€28.27 Million ≈ $33.05 Million	€-802.00K ≈ $-937.62K	-0.028x	+83.21%
2015-12-31	€25.27 Million ≈ $29.55 Million	€-4.27 Million ≈ $-4.99 Million	-0.169x	-101.25%
2014-12-31	€22.01 Million ≈ $25.73 Million	€-1.85 Million ≈ $-2.16 Million	-0.084x	-336.16%
2013-12-31	€13.47 Million ≈ $15.75 Million	€479.00K ≈ $560.00K	0.036x	+136.56%
2012-12-31	€13.98 Million ≈ $16.35 Million	€-1.36 Million ≈ $-1.59 Million	-0.097x	+76.67%
2011-12-31	€8.90 Million ≈ $10.41 Million	€-3.71 Million ≈ $-4.34 Million	-0.417x	-322.48%
2010-12-31	€11.17 Million ≈ $13.05 Million	€-1.10 Million ≈ $-1.29 Million	-0.099x	+67.09%
2009-12-31	€11.78 Million ≈ $13.78 Million	€-3.53 Million ≈ $-4.13 Million	-0.300x	--

About Diagnostic Medical Systems SA

PA:ALDMS France Medical Devices

Market Cap

$33.03 Million

€28.25 Million EUR

Market Cap Rank

#23377 Global

#368 in France

Share Price

€1.09

Change (1 day)

+0.93%

52-Week Range

€1.04 - €1.47

All Time High

€2.70